Completed OBSERVATIONAL NCT01966094

Observational Study of HIV-associated Neurocognitive Disorder (HAND2)

Sponsor: Emory University

Conditions HIV Associated Neurocognitive Disorder Human Immunodeficiency Virus

Updated 11 times since 2017 Last updated: Jul 18, 2018 Started: Oct 31, 2013 Primary completion: Jun 5, 2018 Completion: Jun 5, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01966094, this observational or N/A phase trial focuses on HIV Associated Neurocognitive Disorder and Human Immunodeficiency Virus and remains completed. Sponsored by Emory University, it has been updated 11 times since 2013, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

11 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed
Nov 2020 — Jan 2021 [monthly]

Completed

▶ Show 6 earlier versions

Aug 2018 — Nov 2020 [monthly]

Completed

Status: Recruiting → Completed
Jun 2018 — Aug 2018 [monthly]

Recruiting
May 2018 — Jun 2018 [monthly]

Recruiting
Apr 2018 — May 2018 [monthly]

Recruiting

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Recruiting NA

Phase: PHASE2 → NA
Jan 2017 — Aug 2017 [monthly]

Recruiting PHASE2

First recorded

Oct 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Emory University
National Institute of Mental Health (NIMH)

Data source: Emory University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Atlanta, United States